Creating a culture of clinical research in the clinic: Integrating clinical trials into the care of patients with lupus

ABSTRACT

620 Table 1Clinician-focused opportunities and approaches to cultivate a culture of clinical research in lupus clinical careStrategy Strategies to cultivate a culture of clinical research in clinical care Future directions and opportunities Provide training opportunities for trainees and clinicians • Provide subspecialty fellows/trainees with formal training, practical experience/apprenticeship, and mentorship opportunities to gain experience in clinical trials investigation • Develop and integrate formal training programs throughout medical training and continuing education to develop and strengthen skills and expertise in having effective clinical trial conversations (e.g., verbal and nonverbal skills training, cultural competence and implicit bias training) • Adopt/integrate existing programs such as Materials to Increase Minority Involvement in Clinical Trials (MIMICT), an online accredited CME program through the ACR that focuses on improving clinician knowledge about referring diverse patients to lupus clinical trials21 • Engage diverse stakeholders, including patients, throughout all phases of the development, evaluation, and dissemination of training products Adopt a ‘Universal Precautions' Approach to Educate All Patients About Clinical Trials • Present clinical trial opportunities to all potentially eligible patients (e.g., regardless of beliefs or implicit biases around a patient's willingness to participate or ‘fit' for a trial)• Advocate for consideration of participation, rather than participation11• Offer additional resources for patients to support informed decisions about clinical trial participation• Incorporate teach-back methods to train research personnel as well as to reinforce patient education and understanding• Develop clinical trials materials (including consent forms) in languages other than English • Explore patient preferences for conversations with clinicians about lupus clinical trials• Develop culturally competent, health literate lupus clinical trial-specific information and research materials to support patients in making informed decisions• Diversify clinical research personnel (e.g., bilingual research staff, etc.) Provider Outreach • Engage, exchange information, and build partnerships with rheumatologists, as well as primary care physicians and subspecialists who are closely involved in the care of patients with lupus, as well as health care and research teams • Conduct outreach to create communication and partnerships between academic a d private- practice settings• Encourage outreach to and partnerships with community organizations and stakeholders ReferencesFalasinnu T, Chaichian Y, Bass MB, Simard JF. The representation of gender and race/ethnic groups in randomized clinical trials of individuals with systemic lupus erythematosus. Current Rheumatology Reports. 2018;20(4)20. doi 10.1007/s11926-018-0728-2.Sheikh SZ, Englund TR, Burriss SW, Bull J, Harry A, Groark JG, et al. EMBRACE One small story in lupus—one giant challenge in clinical trials. ACR Open Rheumatology. 2022. doi https//doi.org/10.1002/acr2.11477.Sheikh S, Wanty N, Stephens J, Holtz K, McCalla S. The state of lupus clinical trials minority participation needed. Journal of Clinical Medicine. 2019;8(8). doi 10.3390/jcm8081245.Hamel LM, Penner LA, Albrecht TL, Heath E, Gwede CK, Eggly S. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control. 2016;23(4)327–37. doi 10.1177/107327481602300404Niranjan SJ, Durant RW, Wenzel JA, Cook ED, Fouad MN, Vickers SM, et al. Training needs of clinical and research professionals to optimize minority recruitment and retention in cancer clinical trials. Journal of Cancer Education. 2019;34(1)26–34. doi 10.1007/s13187-017-1261-0.Eggly S, Hamel LM, Heath E, Manning MA, Albrecht TL, Barton E, et al. Partnering around cancer clinical trials (PACCT) study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials. BMC Cancer. 2017;17(1)807. doi 10.1186/s12885-017-3804-5.Eggly S, Manning M, Senft N, Moore TF, Albrecht TL, Penner LA, et al. Development and pilot test of a physician-focused cancer clinical trials communication training intervention. PEC Innovation. 2022;1100012. doi https//doi.org/10.1016/j.pecinn.2021.100012.Avins AL, Goldberg H. Creating a culture of research. Contemporary Clinical Trials. 2007;28(4)557–62. doi https//doi.org/10.1016/j.cct.2007.02.004.McGuinness JE. Strategies to identify and recruit women at high risk for breast cancer to a randomized controlled trial of web-based decision support tools. Cancer Prevention Research. doi 10.1158/1940-6207.CAPR-21-0593.Sood A, Prasad K, Chhatwani L, Shinozaki E, Cha SS, Loehrer LL, et al. Patients‘ attitudes and preferences about participation and recruitment strategies in clinical trials. Mayo Clinic Proceedings. 2009;84(3)243–7. https//doi.org/10.4065/84.3.243.Foster M, Fergusson DA, Hunniford V, Cardenas A, Castillo G, Yaworsky J, et al. Understanding potential barriers and enablers to a perioperative early phase cell therapy trial. Cytotherapy. 2022. https//doi.org/10.1016/j.jcyt.2021.08.008.Balser JR. The Covid-19 pandemic a window into trust within academic medical centers. NEJM Catalyst Innovations in Care Delivery. 2021;2(4).National Academies of Sciences, Engineering, and Medicine. Experiences Implementing Health Literacy Best Practices in Clinical Trials. In Health Literacy in Clinical Research Practice and Impact Proceedings of a Workshop. Wojtowicz A, French MG, editors. Washington, DC The National Academies Press;2020. 120 p.Back AL, Fromme EK, Meier DE. Training clinicians with communication skills needed to match medical treatments to patient values. Journal of the American Geriatrics Society. 2019;67(S2)S435–S41. https//doi.org/10.1111/jgs.15709.Occa A, Leip A, Merritt AS, Stapleton JL. Prevalence and correlates of invitation to participate in clinical trials among US adults. Preventive Medicine Reports. 2022;26101742. https//doi.org/10.1016/j.pmedr.2022.101742.Getz KA. Examining and enabling the role of health care providers as patient engagement facilitators in clinical trials. Clinical Therapeutics. 2017;39(11)2203–13. https//doi.org/10.1016/j.clinthera.2017.09.014.Lima K, Phillip CR, Williams J, Peterson J, Feldman CH, Ramsey-Goldman R. Factors associated with participation in rheumatic disease–related research among underrepresented populations a qualitative systematic review. Arthr tis Care & Research. 2020;72(10)1481–9. https//doi.org/10.1002/acr.24036.Patel S, Pelletier-Bui A, Smith S, Roberts MB, Kilgannon H, Trzeciak S, et al. Curricula for empathy and compassion training in medical education A systematic review. PLOS ONE. 2019;14(8) e0221412. doi 10.1371/journal.pone.0221412.Sneed RS, Mason M, Williams JN, Sinnette C Taber K, Mancera-Cuevas K, et al. Using critical race theory to understand trial participation among black individuals with systemic lupus erythematosus a qualitative study of patients and caregivers. Arthritis Care & Research. 2021;73(10)1387–95. https//doi.org/10.1002/acr.24635.Georgopoulou S, Prothero L, D'Cruz DP. Physician–patient communication in rheumatology a systematic review. Rheumatology International. 2018;38(5)763–75. doi 10.1007/s00296-018- 4016-2.American College of Rheumatology. Materials to Increase Minority Involvement in Clinical Trials. Online Education Course. [Webpage]. Accessed July 20, 2022. https//thelupusinitiative.org/mimict-2/providers/online-education-course/